Transsphenoidal Hypophysectomy for Pituitary Tumors

Transsphenoidal hypophysectomy is the surgical removal of part or all of the pituitary gland through the nose and sphenoid sinus, bypassing the need to open the skull. It is the preferred operation for most pituitary tumors, and its name breaks down simply: “trans” (through), “sphenoidal” (the sphenoid bone behind the nose), and “hypophysectomy” (removal of the hypophysis, the medical name for the pituitary gland). The procedure has been refined over more than a century, and modern versions using an endoscope or microscope achieve gross-total tumor removal in roughly 80% of cases, with mortality rates near zero in experienced centers.

Why Operate Through the Nose

The pituitary gland sits in a small bony cup called the sella turcica, right behind the sphenoid sinus. That sinus is an air-filled cavity you can reach directly through the nostrils, which makes it a natural corridor to the pituitary without having to lift or retract the brain. Early attempts at reaching the pituitary in the late 1800s and early 1900s used transcranial routes, going through the skull from above. The mortality rates were considered prohibitive. In 1906, an Austrian surgeon named Schloffer reported the first successful pituitary tumor removal through the nose, and over the following years the approach was steadily refined.

The anatomy of the sphenoid sinus varies from person to person, which matters for surgical planning. In a study of normal adults, about 63% had a gently curved sellar floor, 25% had a prominently bulging floor, and roughly 11% had a flat one. Patients with pituitary tumors were more likely to have a prominent sellar floor, since the growing tumor pushes the bone outward. About 71% of people have a simple sinus layout with few or symmetrical bony walls (septa) inside the sinus, while 29% have a complex arrangement with multiple asymmetrical septa that the surgeon must navigate around.¹

A Century of Refinement

After Schloffer’s 1906 breakthrough, several surgeons improved the technique in quick succession. By 1910, Halstead had described the sublabial incision, entering through a cut under the upper lip rather than making external incisions on the face. Harvey Cushing, perhaps the most famous name in early neurosurgery, combined these innovations and used the transsphenoidal route on 231 pituitary tumors between 1910 and 1925, with a mortality rate of about 5.6%. But Cushing eventually shifted to transcranial surgery, which let him see and decompress the optic nerves better, and most surgeons followed his lead.²

The transsphenoidal route survived thanks to Norman Dott, a Scottish surgeon who had trained with Cushing and kept performing the nasal approach when almost no one else would. Dott passed it on to Gerard Guiot in France, who published strong results in the early 1960s and revived European interest. Then Jules Hardy, working with Guiot, introduced the operating microscope and intraoperative fluoroscopy, giving surgeons vastly better visualization of the tiny structures around the pituitary. Combined with antibiotics and finer instruments, the transsphenoidal approach became the standard route for tumors confined to the sella turcica, where it remains today.³

Microscopic Versus Endoscopic Technique

Modern transsphenoidal surgery is performed one of two ways. The microscopic technique uses an operating microscope placed outside the nose, viewing down a narrow corridor created with a nasal speculum. The endoscopic technique threads a thin camera directly into the nasal cavity, projecting a wide-angle image onto a screen. Both are well established, and the choice between them often comes down to the surgeon’s training and the specific tumor’s characteristics.

A prospective multicenter study comparing the two approaches for nonfunctioning pituitary tumors found gross-total resection in 80% of microscopic cases and about 84% of endoscopic cases, with no statistically significant difference.⁴ A separate comparison found total radiological remission in about 65% of patients in both groups, with hormonal remission slightly higher in the endoscopic group but not by a statistically meaningful margin.⁵

A systematic review and meta-analysis pooling data from many series found no significant difference in death rate, cerebrospinal fluid leak, meningitis, visual complications, diabetes insipidus, or overall completeness of resection between the two methods. One finding that did stand out: the endoscopic approach carried a higher rate of vascular complications.⁶ That said, the endoscopic technique’s wider field of view is a meaningful advantage when tumors extend beyond the sella into surrounding areas, and it has become the dominant approach at most high-volume centers.

From a cost perspective, a modeling study found that endoscopic surgery cost on average about $143 less than microscopic surgery over two years and produced a small gain in quality-adjusted life, an advantage that grew larger when modeled out to ten years.⁷

Technology Inside the Operating Room

Two technologies have meaningfully changed how transsphenoidal surgery is performed. Neuronavigation, a GPS-like system that tracks the surgeon’s instruments against preoperative imaging in real time, has been shown in a systematic review and meta-analysis to increase the rate of complete tumor removal and reduce postoperative complications.⁸ It is especially helpful in patients with unusual sinus anatomy, where the bony landmarks the surgeon typically relies on are misleading.

Intraoperative MRI takes things further. In one early series of patients with large pituitary tumors, scanning during surgery revealed residual tumor that would otherwise have been left behind. Those scans prompted additional resection in several cases, converting the complete-removal rate from 60% to 80%.⁹ The equipment is expensive and not available everywhere, but for large or complex tumors, it can make the difference between needing a second surgery or not.

What Can Go Wrong During Surgery

Transsphenoidal surgery is considered safe compared with most intracranial operations, but the corridor to the pituitary runs between the two internal carotid arteries, among the body’s most important blood vessels. Injury to one of these arteries is rare but potentially devastating. In one series reporting six such injuries during endoscopic surgery, all were controlled with immediate packing followed by endovascular treatment, and no serious long-term complications resulted.¹⁰ A larger case series of ten patients found that the most common cause of carotid injury was the drill used to open the sellar floor, and that revision surgeries carried a higher risk. When the injured artery could not be directly repaired, the standard approach involved packing, followed by angiography and, in most cases, endovascular sacrifice of the damaged vessel.¹¹

The more common complication is cerebrospinal fluid (CSF) leak, where the protective fluid surrounding the brain drains through the surgical opening. Rates of intraoperative CSF leak run around 39% in some series, but the introduction of the nasoseptal flap, a tissue flap harvested from the nasal septum and laid over the defect, has dramatically reduced the rate of persistent postoperative leaks. One center reported zero postoperative CSF leaks after routinely using nasoseptal flaps for reconstruction.¹² A comparison between microscopic and endoscopic series at another institution found postoperative CSF leak rates of about 12.5% with microscopic repair techniques versus 3% when endoscopic flap repair was used.¹³

Hormonal Consequences

The pituitary gland controls thyroid function, adrenal function, growth, reproduction, and water balance. Removing a tumor from this gland can disrupt any of those systems, either temporarily or permanently. In a large series of patients undergoing transsphenoidal adenoma removal, new anterior pituitary hormone loss occurred in about 5.5% of patients, and permanent diabetes insipidus, a condition where the kidneys cannot concentrate urine and the patient becomes extremely thirsty, developed in about 2%.¹⁴

On the encouraging side, nearly half of patients who had hormonal dysfunction before surgery saw improvement afterward. Elevated prolactin caused by stalk compression, a common finding when a tumor presses on the pituitary stalk, resolved in about 73% of cases.¹⁵ Among patients with nonfunctioning adenomas specifically, about 80% had some degree of anterior pituitary dysfunction before surgery, and recovery rates for individual hormone axes were substantial: thyroid hormone recovery occurred in roughly 85-88% of those who had been deficient, and growth factor levels recovered in about 78%.¹⁶

Diabetes insipidus deserves special attention because it is the most common early postoperative endocrine problem. Transient diabetes insipidus was most frequent in patients with Cushing’s disease, occurring in about 78% of those cases in one study, while permanent diabetes insipidus was more common in nonfunctioning adenomas at about 7%. Tumor size and higher preoperative sodium levels were associated with both transient and permanent forms.¹⁷ Current guidelines recommend against giving scheduled doses of the replacement drug desmopressin in the first week after surgery, because the condition often resolves on its own and scheduled dosing risks dangerous drops in sodium levels.¹⁸

Pituitary apoplexy, the sudden hemorrhage or loss of blood supply to a pituitary tumor, creates a somewhat different hormonal picture. Patients who present with apoplexy tend to have higher rates of adrenal insufficiency both before and after surgery. Three years after the operation, one study found that patients in the apoplexy group still had a significantly higher rate of adrenal axis deficiency and reproductive hormone deficiency compared with those who did not have apoplexy.¹⁹

Vision Recovery

Many people with pituitary tumors first notice something is wrong because of vision changes, typically a loss of peripheral vision in both eyes caused by the tumor pressing on the optic nerves just above the pituitary. One of the main goals of surgery is to relieve that pressure. Research into visual field recovery after pituitary tumor removal suggests it happens in phases. The fastest improvement occurs within the first week, where some patients experience near-normalization. A slower but still substantial phase of improvement continues from about one to four months. After that, a late phase extending to roughly three years may yield mild additional gains, though these are less consistent.²⁰

A meta-analysis looking at predictive factors confirmed that visual field scores improve significantly after surgery, with younger patients, shorter symptom duration, and smaller tumors tending to predict better recovery.²¹ The implication for patients is that earlier intervention, before nerve damage becomes entrenched, tends to produce better visual outcomes.

What Happens After Surgery

Hospital stays after transsphenoidal surgery have shortened considerably. A prospective trial of a short-stay protocol demonstrated that most patients could be safely discharged after a single overnight stay, with low complication and readmission rates.²² In practice, many centers keep patients for one to three nights, monitoring sodium levels closely to catch delayed swings in water balance that can occur seven to ten days after surgery.

Endocrine follow-up is crucial. Expert consensus recommends retesting all pituitary hormone axes starting at about six weeks after surgery. Thyroid function is typically checked first, at six to eight weeks, since untreated hypothyroidism has immediate effects on energy and well-being. Reproductive hormones and growth factors are evaluated at around twelve weeks. Dynamic testing for growth hormone deficiency may be considered in patients with clinical suspicion.²³ Some patients will need lifelong hormone replacement for one or more axes; others will recover function entirely.

Recurrence and Long-Term Monitoring

Pituitary tumors can come back. The most reliable predictor of recurrence differs by tumor type. For hormone-producing (functioning) tumors, the strongest predictor is the postoperative basal hormone level. If hormone levels do not normalize after surgery, the risk of regrowth is substantially higher.²⁴ For nonfunctioning tumors, no single factor is a convincing predictor, though residual tumor on postoperative imaging, tumor size, invasion into surrounding structures, and certain tumor subtypes have all been identified as risk factors.²⁵

When tumors do recur, repeat transsphenoidal surgery is an option, and radiation therapy or radiosurgery may also be used. No consensus protocol exists for which approach is best in recurrent disease, and the decision depends on the tumor type, its growth pattern, and prior treatments.²⁶ Long-term surveillance with periodic MRI scans and hormonal testing is standard for all patients, often continuing for a decade or more.

Smell and Quality of Life After the Operation

Because the surgical route passes through the nasal cavity, some degree of olfactory disruption is common. One study found that about two-thirds of patients had measurably reduced smell after endoscopic single-nostril surgery, and roughly 15% had long-term olfactory dysfunction. Smoking and persistent nasal symptoms were the strongest risk factors, with smokers facing dramatically higher odds of lasting smell problems.²⁷ A separate study confirmed smoking history and the anatomical angle of the sphenoid sinus as predictors of patient-reported olfactory dysfunction, but also found that smell tended to improve with time after surgery.²⁸

This is worth knowing ahead of time. A patient who works in food, perfumery, or any profession that depends on smell should discuss the risk explicitly with their surgeon. Quitting smoking before the operation appears to offer genuine protection.

Transsphenoidal Surgery in Children

Pituitary tumors are uncommon in children, but they do occur, and the transsphenoidal approach is used in pediatric patients as well. In a study of 42 children and adolescents with Cushing’s disease treated with transsphenoidal surgery, the initial remission rate was 83%, dropping to a net remission rate of 73% over the long term due to late relapses. The authors emphasized the need for prolonged follow-up in this age group.²⁹ A multicenter series covering the broader range of pediatric pituitary adenomas, including growth-hormone-producing and nonfunctioning tumors, reported remission in about 81% of patients, with some achieving remission after a second operation.³⁰

Smaller nasal passages and still-developing sinuses make the procedure technically more challenging in children. An analysis of a national pediatric database found that the use of image guidance (neuronavigation) in children was associated with a lower risk of postoperative diabetes insipidus and a shorter hospital stay by nearly three days, with no increase in cost.³¹

How Preoperative Imaging Is Evolving

Knowing what a tumor feels like before the surgeon touches it sounds futuristic, but that is exactly where preoperative MRI analysis is headed. The consistency of a pituitary tumor, whether it is soft and suckable or firm and fibrous, changes the surgical strategy entirely. Researchers have shown that machine-learning analysis of standard T2-weighted MRI images can predict tumor consistency before the operation.³² More recent multicenter work has extended this to multiparametric MRI models combining several image types, achieving even better predictive accuracy.³³ This kind of information helps the surgical team choose instruments, plan the extent of the opening, and set realistic expectations for whether complete removal is likely in a single sitting.

Simulation training is another growing area. A study comparing practice on 3D-printed models with cadaveric training found that both residents and experienced surgeons significantly improved their endoscopic skills through simulation-based programs.³⁴ As 3D printing becomes cheaper and more detailed, this kind of rehearsal may eventually be done on patient-specific models, letting a surgeon practice navigating an individual’s unique sinus anatomy before the real procedure begins.